C3 and Alzheimer disease: Moreover, we previously reported an increased release of C3-containing EVs by choroid plexus epithelial (CPE) cells that were stimulated with amyloid-beta oligomers (AβO), identifying a novel source of complement-containing EVs that might potentially be detected in the CSF as biomarker for AD (151).